The stock of Cano Health Inc. (NYSE:CANO) increased by $0.03 on Monday to finish at $0.44, up 8.07 percent. The last five days have seen an average of 31,207,441 shares of common stock traded. 7 times new highs were reached in the current year, with a fall of -$0.9265. The average number of shares traded over the last 20 days was 10,312,835, while the average volume over the last 50 days totaled 6,963,284.
CANO stock dropped -68.09% since last month. On 08/14/23, the company’s shares reached a one-month low of $0.3439. The stock touched a high of $9.75 on 02/08/23, after rallying from a low of $0.38 in 52 weeks. The price of CANO stock has declined by -67.63% or -$0.9265 this year, reaching a new high 7 times. Still, the stock price is down -95.45% from the 52-week high.
Top 5 AI Stocks to Buy for 2023
The artificial intelligence (AI) revolution is already here. And it's about to change everything we know about everything.
According to Grand View Research, the global AI boom could grow from about $137 billion in 2022 to more than $1.81 trillion by 2030. And investors like you always want to get in on the hottest stocks of tomorrow. Here are five of the best ways to profit from the AI boom.
Click Here to Download the FREE Report.
Sponsored
Insider Transactions
CANO stock investors should be aware that Cano Health Inc. (CANO) stock had its last reported insider trading activity 47 days ago on Jun 29. On Jun 29, Chief Clinical Officer Aguilar Richard sold 400,000 shares at $1.31 each. This transaction resulted in the insider making $525,760. On Jun 28, Aguilar Richard sold 150,000 shares at a price of US$1.22. After the transaction, the insider now owns 1,613,984 shares. Chief Clinical Officer Aguilar Richard had earlier sold 500,000 shares on Jun 12 for $1.42 a share. The transaction was completed for $711,650.
Valuation Metrics
Beta for the stock is 0.28. There are also a few other valuation ratios worth considering, including the trailing price-to-sales (P/S) ratio of 0.30, the price-to-book (PB) ratio of 0.39.
Financial Health
For the three months ended June 29, Cano Health Inc.’s current ratio was 0.50. The company’s long-term debt to equity ratio for the quarter ending June 29 is 6.34, and the total debt to equity ratio is 7.11. Cano Health Inc.’s EBITDA margin for the year ended June 29 was 0.60%, whereas its operating margin stood at -23.40% for the same period. Based on annual data, it had gross profit of $3.18 billion and revenue of $2.74 billion.
Investors will also look at the performance of the company’s management in order to determine the potential profitability of their investment. There was a -34.90% return on investment (ROI) in the past year.
Earnings Surprise
According to Cano Health Inc.’s quarterly financial report for the quarter that ended June 29. A lower net income was reported in the quarter under review than the previous quarter. Net income for the quarter came in at $766.75 million, while revenues rose by 10.09% to $866.91 million. It was predicted that Cano Health Inc.’s quarterly earnings would be -$0.51, but it ended up being -$0.12, beating the consensus by -325.00%. EBITDA was -$216.94 million for the quarter. At the end of Cano Health Inc.’s most recent quarter ended June 29, its liabilities totaled 1.47 billion, while its total debt was $1.23 billion. Equity owned by shareholders amounts to $538.68 million.
Technical Picture
Here’s a quick look at Cano Health Inc.’s (CANO) price momentum from a technical perspective. As of 14 August, the RSI 9-day stood at 18.31%, suggesting the stock is oversold, with a 663.61% historical volatility rate.
The stochastic %K and %D were 19.68% and 40.11% respectively, while the average true range (ATR) was 0.2273. Based on the 14-day stochastic reading of 7.13%, the RSI (14) reading is 24.15%. On the 9-day MACD Oscillator, the stock is at -0.5402, and the 14-day reading is at -0.5647.
Analyst Ratings
Cano Health Inc. (NYSE: CANO) was downgraded by Jefferies to a a Hold rating in its latest research report. The stock was previously rated as a a Buy. Analysts have assigned Cano Health Inc. (CANO) an Hold rating. CANO is a stock that is recommended for selling by 1 brokerage firm, while 6 companies recommend holding. The stock is underweighted by 1 analyst. Among the analysts who rate the stock, 0 rates it overweight and 1 other recommend it as a buy.
What is CANO’s price target for the next 12 months?
The current consensus forecast for the stock is between $0.50 and $3.00, with a median target price of $1.00. In analyzing these forecasts, the average price target given by analysts for Cano Health Inc. (CANO) is $1.33.
